C-X-C-Chemokine-Receptor-Type-4 Inhibitor AMD3100 Attenuates Pulmonary Inflammation and Fibrosis in Silicotic Mice
Qixian Sun,1 Xinrong Tao,1- 4 Bing Li,1 Hangbing Cao,1 Haoming Chen,1 Yuanjie Zou,1 Huihui Tao,1- 4 Min Mu,1- 4 Wenyang Wang,1 Keyi Xu1- 4 1Center for Medical Research, Medical School, Anhui University of Science and Technology, Huainan, People's Republic of China; 2Key Laboratory of Industrial...
Saved in:
Main Authors: | Sun Q (Author), Tao X (Author), Li B (Author), Cao H (Author), Chen H (Author), Zou Y (Author), Tao H (Author), Mu M (Author), Wang W (Author), Xu K (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of CXCR4 in Spinal Cord and DRG with AMD3100 Attenuates Colon-Bladder Cross-Organ Sensitization
by: Zhang H, et al.
Published: (2022) -
Potentiating effect of AMD3100 on bone morphogenetic protein-2 induced bone regeneration
by: Gyu-Jo Shim, et al.
Published: (2024) -
Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
by: Zhang M, et al.
Published: (2022) -
CX3C chemokine: Hallmarks of fibrosis and ageing
by: Xuanning Chen, et al.
Published: (2024) -
AMD3100 Attenuates Post-Traumatic Osteoarthritis by Maintaining Transforming Growth Factor-β1-Induced Expression of Tissue Inhibitor of Metalloproteinase-3 via the Phosphatidylinositol 3-Kinase/Akt Pathway
by: Weiwei Lu, et al.
Published: (2020)